Introduction
Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Huntington's disease, are characterized by neuronal loss and/or neuronal death [1] . Neurotrophic factors (NTFs), including nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) can be used for the treatment of neurodegenerative disease [2] .
However, these large NTFs cannot cross the blood-brain barrier and are easily degraded [3] . To address this issue, researchers have been screening small molecular compounds that have neurotrophic properties or are able to enhance the action of NTFs [1] [2] [3] .
Zushima is a common traditional Chinese medicine which is distributed in Sichuan, Shanxi and Gansu Provinces, China [4] . It contains many pharmacologically active com-494 pounds such as coumarins, lignans, flavonoids and diterpenoids [5] . Among these compounds, 7,8-dihydroxycoumarin (DHC), also called daphnetin, has been isolated from Zushima and used to treat coagulation disorders and rheumatoid arthritis [6, 7] . A number of biological activities of DHC, such as anti-inflammatory, antioxidant [8] , antimicrobial [9] and antimalarial [10] effects, have been demonstrated. However, the neurotrophic effects of DHC remain to be reported. The present study aimed to investigate the neurotrophic effects of DHC in primary cultured rat cortical neurons.
Materials and methods

Drugs DHC (>97% pure) was from the National
Institute for the Control of Pharmaceutical and Biological Products, China (Fig. 1 ). and incubated at 37°C in a humidified atmosphere of 95% air and 5% CO 2 .
Cell culture
Immunocytochemistry Immunocytochemical staining
was used to identify cells in cultures [1, 11] . Cortical cells were cultured as described above and seeded at 6 × 10 and the band intensity of MAP2 and GAPDH was quantified using the Gel-Pro software (Media Cybernetics Inc.).
Assessment of cortical neuron viability
Statistical analysis
All data are expressed as mean ± SEM from at least 3 independent experiments, and analyzed using one-way ANOVA, followed by the Bonferroni post hoc test. P <0.05 was considered to be statistically significant.
Results
Identification of neurons Cortical cells from new-
born rats were cultured for 3 days, and then underwent immunocytochemical staining using anti-MAP2 antibody and Hoechst 33258 to identify the neurons. Under the inverted microscope, the cells showed clear cell bodies and processes; most stained for MAP2 and so were neurons (Fig. 2 ).
Neurite outgrowth assay
As shown by MAP2 immunofluorescence staining, neurons treated with different doses of DHC had longer processes than those of vehicle control (Fig. 3) . Only neurites greater than twice the length of the soma were counted. Compared with 10 ng/ mL bFGF, 4 and 8 μmol/L DHC had a stronger effect in promoting neurite outgrowth. These observations suggest that DHC enhanced neurite outgrowth in a dose-dependent manner (Figs. 3, 4 ).
Cortical neuron viability As revealed by MTT as-
say, the viability of cortical neurons significantly increased after treatment with 2, 4, and 8 μmol/L DHC compared to vehicle control (Fig. 5) . LDH release assay further confirmed the neurotrophic effect of DHC on neuronal survival.
Consistently, LDH release decreased significantly after (Fig. 6 ). (Fig. 7) . We also found that BDNF mRNA expression was significantly enhanced in cortical neurons by DHC in a dose-dependent manner (Fig. 8 ).
RT-PCR for MAP2 and BDNF mRNA
Discussion
The system of cortical neuronal culture uses a serum- free medium [12] . This is a common and useful model for studying neurotrophic effects, neuroprotective properties and other neurobiological events [13] . DHC, administered at different concentrations, promoted neurite outgrowth and neuronal survival. By MTT assay and LDH assay, we found that DHC enhanced neuronal viability and promoted neurite outgrowth at 2, 4 and 8 μmol/L.
It is known that neurons abundantly express MAP2, which can be used as specific marker to identify immature and mature neurons [14] . Our results showed that most of the cultured cells were neurons (Fig. 2) . MAP2 guides microtubules to extend towards specific cellular spaces and cross-link with other microtubules, and also modulates the interactions of microtubules with other proteins in neurons [15] . Therefore, MAP2 plays an important role in maintaining neuronal shape and stabilization, and regulating neurite growth [16] .
BDNF is widely found in the cortex, hippocampus and basal forebrain, and is associated with several neurological disorders [17, 18] , contributing to the survival of neurons, promoting neuronal growth and differentiation, and inducing the formation of new synapses [19] . Thus, BDNF is also associated with learning and memory [20] . Research on the mechanism of action of BDNF showed that it acts on various neurotransmitter receptors, including TrkA, TrkB, LNGFR and the alpha-7 nicotinic receptor [17] . The Trk receptor and p75NTR are receptors for neurotrophin, and have a special structural base suitable for neurotrophin signaling. Many studies have noted that an increase of BDNF secretion in the cortex has potentially neuroprotective and neurotrophic effects [17] [18] [19] 21] . In this study, we found that the mRNA expression of both BDNF and MAP2 in the DHCtreated groups was enhanced compared with that in the vehicle groups.
In conclusion, the present study evaluated the neurotrophic effects of DHC isolated from Zushima. DHC increased BDNF expression in a dose-dependent manner, which might be the mechanism underlying its neurotrophic effects. Therefore, DHC can be regarded as a potential drug for the treatment of neurodegenerative diseases.
